JP2016510326A5 - - Google Patents

Download PDF

Info

Publication number
JP2016510326A5
JP2016510326A5 JP2015553856A JP2015553856A JP2016510326A5 JP 2016510326 A5 JP2016510326 A5 JP 2016510326A5 JP 2015553856 A JP2015553856 A JP 2015553856A JP 2015553856 A JP2015553856 A JP 2015553856A JP 2016510326 A5 JP2016510326 A5 JP 2016510326A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
treatment
compound
cardiovascular disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015553856A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016510326A (ja
JP6449171B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/012085 external-priority patent/WO2014113696A1/en
Publication of JP2016510326A publication Critical patent/JP2016510326A/ja
Publication of JP2016510326A5 publication Critical patent/JP2016510326A5/ja
Application granted granted Critical
Publication of JP6449171B2 publication Critical patent/JP6449171B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015553856A 2013-01-18 2014-01-17 治療指数の改善されたニトロキシル供与体 Expired - Fee Related JP6449171B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361754237P 2013-01-18 2013-01-18
US61/754,237 2013-01-18
US201361782781P 2013-03-14 2013-03-14
US61/782,781 2013-03-14
PCT/US2014/012085 WO2014113696A1 (en) 2013-01-18 2014-01-17 Nitroxyl donors with improved therapeutic index

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2017005276A Division JP6311038B2 (ja) 2013-01-18 2017-01-16 治療指数の改善されたニトロキシル供与体
JP2018228317A Division JP6656345B2 (ja) 2013-01-18 2018-12-05 治療指数の改善されたニトロキシル供与体

Publications (3)

Publication Number Publication Date
JP2016510326A JP2016510326A (ja) 2016-04-07
JP2016510326A5 true JP2016510326A5 (enExample) 2017-02-23
JP6449171B2 JP6449171B2 (ja) 2019-01-09

Family

ID=50064795

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015553858A Expired - Fee Related JP6533159B2 (ja) 2013-01-18 2014-01-17 ニトロキシル供与体を含む医薬組成物
JP2015553856A Expired - Fee Related JP6449171B2 (ja) 2013-01-18 2014-01-17 治療指数の改善されたニトロキシル供与体
JP2017005276A Expired - Fee Related JP6311038B2 (ja) 2013-01-18 2017-01-16 治療指数の改善されたニトロキシル供与体
JP2018228317A Active JP6656345B2 (ja) 2013-01-18 2018-12-05 治療指数の改善されたニトロキシル供与体
JP2019096869A Expired - Fee Related JP6801045B2 (ja) 2013-01-18 2019-05-23 ニトロキシル供与体を含む医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015553858A Expired - Fee Related JP6533159B2 (ja) 2013-01-18 2014-01-17 ニトロキシル供与体を含む医薬組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2017005276A Expired - Fee Related JP6311038B2 (ja) 2013-01-18 2017-01-16 治療指数の改善されたニトロキシル供与体
JP2018228317A Active JP6656345B2 (ja) 2013-01-18 2018-12-05 治療指数の改善されたニトロキシル供与体
JP2019096869A Expired - Fee Related JP6801045B2 (ja) 2013-01-18 2019-05-23 ニトロキシル供与体を含む医薬組成物

Country Status (29)

Country Link
US (13) US8987326B2 (enExample)
EP (5) EP3284463B1 (enExample)
JP (5) JP6533159B2 (enExample)
KR (2) KR102177899B1 (enExample)
CN (4) CN110179777B (enExample)
AU (5) AU2014207404B2 (enExample)
BR (2) BR112015017251B1 (enExample)
CA (2) CA2898445C (enExample)
CY (3) CY1120535T1 (enExample)
DK (3) DK3284463T3 (enExample)
ES (4) ES2659969T3 (enExample)
HK (1) HK1251170B (enExample)
HR (3) HRP20180121T1 (enExample)
HU (3) HUE036589T2 (enExample)
IL (4) IL239906B (enExample)
LT (3) LT3284463T (enExample)
MX (2) MX363843B (enExample)
NZ (4) NZ709986A (enExample)
PL (3) PL2945621T3 (enExample)
PT (3) PT2945620T (enExample)
RS (3) RS59434B1 (enExample)
RU (3) RU2684916C2 (enExample)
SG (6) SG11201505568PA (enExample)
SI (3) SI2945620T1 (enExample)
SM (3) SMT201900575T1 (enExample)
TR (1) TR201802211T4 (enExample)
TW (3) TWI712409B (enExample)
WO (2) WO2014113696A1 (enExample)
ZA (2) ZA201505090B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE029309T2 (en) 2006-03-17 2017-02-28 Univ Johns Hopkins N-hydroxylsulfonamide derivatives as novel physiologically useful nitroxyl donors
CA2852914C (en) 2011-10-17 2019-11-26 The Johns Hopkins University Meldrum's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors
BR112015017251B1 (pt) 2013-01-18 2021-10-26 Cardioxyl Pharmaceuticals, Inc. Composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas
ES2734060T3 (es) 2014-01-17 2019-12-04 Cardioxyl Pharmaceuticals Inc Donadores de nitroxilo de N-hidroximetanosulfonamida
ES2749682T3 (es) 2014-05-27 2020-03-23 Cardioxyl Pharmaceuticals Inc Derivados de pirazolona como donadores de nitroxilo
US9464061B2 (en) 2014-05-27 2016-10-11 The Johns Hopkins University N-hydroxylamino-barbituric acid derivatives
CN108349911B (zh) 2015-09-07 2022-05-13 浙江华海药业股份有限公司 可释放一氧化氮的前药分子
JP6889704B2 (ja) 2015-10-19 2021-06-18 カルディオキシル ファーマシューティカルズ,インク. ニトロキシルドナーとしてのピラゾロン誘導体
EP3365325A1 (en) 2015-10-19 2018-08-29 Cardioxyl Pharmaceuticals Inc. N-hydroxylsulfonamide derivatives as nitroxyl donors
KR20190070912A (ko) 2016-07-28 2019-06-21 더 존스 홉킨스 유니버시티 O-치환된 히드록삼산
AU2018205621B2 (en) * 2017-01-03 2023-01-05 Cardioxyl Pharmaceuticals, Inc. Method of administering nitroxyl donating compounds
CN110536683A (zh) * 2017-04-18 2019-12-03 基恩菲特公司 包含PPAR激动剂如伊拉非诺和乙酰CoA羧化酶ACC抑制剂的组合
CN116283762B (zh) * 2023-03-28 2025-08-12 昆山市第一人民医院 一种用于制备白鲜碱的中间体化合物及其制备方法、白鲜碱的制备方法
WO2025043108A1 (en) 2023-08-23 2025-02-27 Bristol -Myers S Quibb Company Co-crystals of nitroxyl donating compounds

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1017976A (en) 1911-08-25 1912-02-20 Rudolph Koch Automatic mail-bag catcher and deliverer.
US1021340A (en) 1911-10-14 1912-03-26 William A Scott Means for attaching binding-posts to dry batteries.
US3751255A (en) 1972-03-24 1973-08-07 Eastman Kodak Co Photosensitive and thermosensitive element, composition and process
JPS567710A (en) 1979-06-28 1981-01-27 Sansho Seiyaku Kk Whitening cosmetic
US4539321A (en) 1981-10-26 1985-09-03 William H. Rorer, Inc. 5-Diaza-aryl-3-substituted pyridone compounds
ATE66143T1 (de) 1985-01-11 1991-08-15 Abbott Lab Feste zubereitung mit langsamer freisetzung.
US4663351A (en) 1985-08-23 1987-05-05 Berlex Laboratories, Inc. Dobutamine tri-isobutyric acid ester and the use thereof as a cardiotonic agent
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
JPH01221371A (ja) 1988-02-29 1989-09-04 Hokko Chem Ind Co Ltd 環状オキシアミン誘導体の製造方法
JPH01221372A (ja) 1988-03-01 1989-09-04 Hokko Chem Ind Co Ltd 環状アシルヒドロキシルアミン誘導体
JPH0221372A (ja) 1988-07-08 1990-01-24 Sharp Corp はんだ付検査装置
JPH0828240B2 (ja) 1990-05-25 1996-03-21 矢崎総業株式会社 電線相互の圧着接続構造及び圧着接続方法
JP2773959B2 (ja) 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
JPH04321671A (ja) 1991-04-17 1992-11-11 Mitsubishi Petrochem Co Ltd カルバモイルトリアゾール誘導体およびそれを有効成分とする除草剤
CN1143950A (zh) * 1994-01-19 1997-02-26 比克荷兰有限公司 含硝酰基的苄胺衍生物及其在治疗心血管疾病和治疗升高眼压中的应用
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
JPH10142729A (ja) 1996-11-05 1998-05-29 Fuji Photo Film Co Ltd 熱現像画像記録材料
CA2306914A1 (en) 1997-10-24 1999-05-06 Shionogi & Co., Ltd. Antirheumatic
ATE236136T1 (de) * 1998-01-16 2003-04-15 Hoffmann La Roche Benzosulfonderivate
US6295153B1 (en) 1998-06-04 2001-09-25 Board Of Regents, The University Of Texas System Digital optical chemistry micromirror imager
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
AU4800999A (en) 1998-07-28 2000-02-21 Tanabe Seiyaku Co., Ltd. Preparation capable of releasing drug at target site in intestine
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
JP2002072459A (ja) 2000-08-28 2002-03-12 Toyo Gosei Kogyo Kk 光酸発生剤及びそれを含有する感光性樹脂組成物
ES2267853T3 (es) 2000-12-13 2007-03-16 Wyeth Inhibidroes de sulfonamida heteriociclicos de la produccion de beta amiloides.
EP1219306A1 (en) * 2000-12-29 2002-07-03 Nicox S.A. Compositions comprising cyclodextrins and NO- releasing drugs
GB0114223D0 (en) 2001-06-12 2001-08-01 Ici Plc Catalytic oxidation process
US20040038947A1 (en) 2002-06-14 2004-02-26 The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services Method of treating ischemia/reperfusion injury with nitroxyl donors
US6936639B2 (en) 2002-08-21 2005-08-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitroxyl progenitors in the treatment of heart failure
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
WO2005061519A1 (en) 2003-12-19 2005-07-07 Takeda San Diego, Inc. Kinase inhibitors
US20090281067A1 (en) 2004-01-30 2009-11-12 The John Hopkins University Nitroxyl progenitor compounds and methods of use
US8168771B2 (en) 2005-01-31 2012-05-01 The Johns Hopkins University Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
JP2008543947A (ja) 2005-06-23 2008-12-04 ジョンズ ホプキンス ユニバーシティ チオール感受性の正の変力物質
HUE029309T2 (en) 2006-03-17 2017-02-28 Univ Johns Hopkins N-hydroxylsulfonamide derivatives as novel physiologically useful nitroxyl donors
EP2010476A4 (en) 2006-04-13 2011-01-26 Univ Wake Forest Health Sciences NITROXYL DISPENSERS FROM C-NITROSO COMPOUNDS
MX2010003232A (es) 2007-09-26 2010-08-23 Univ Johns Hopkins Derivados de n-hidroxisulfonamida como nuevos donadores de nitroxilo fisiologicamente utiles.
HUE030372T2 (en) * 2008-05-07 2017-05-29 Cardioxyl Pharmaceuticals Inc New nitroso compounds as nitroxyl donors and methods for their use
WO2011063339A1 (en) 2009-11-23 2011-05-26 Cardioxyl Pharmaceuticals, Inc. Nitroxyl donors for the treatment of pulmonary hypertension
WO2011071951A2 (en) 2009-12-07 2011-06-16 Johns Hopkins University N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
JP5832447B2 (ja) 2009-12-07 2015-12-16 ザ ジョンズ ホプキンス ユニバーシティ ビスアシル化ヒドロキシルアミン誘導体
CA2852914C (en) 2011-10-17 2019-11-26 The Johns Hopkins University Meldrum's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors
EP2914579A1 (en) 2012-11-01 2015-09-09 The Johns Hopkins University Controlled hno release through intramolecular cyclization-elimination
BR112015017251B1 (pt) 2013-01-18 2021-10-26 Cardioxyl Pharmaceuticals, Inc. Composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas
ES2734060T3 (es) 2014-01-17 2019-12-04 Cardioxyl Pharmaceuticals Inc Donadores de nitroxilo de N-hidroximetanosulfonamida
US9464061B2 (en) 2014-05-27 2016-10-11 The Johns Hopkins University N-hydroxylamino-barbituric acid derivatives

Similar Documents

Publication Publication Date Title
JP2019524883A5 (enExample)
JP2015057451A5 (enExample)
JP2016518337A5 (enExample)
JP2013519675A5 (enExample)
JP2016528301A5 (enExample)
JP2014077003A5 (enExample)
CN110036005A (zh) 酰胺衍生物及其在药物中的应用
JP2013542247A5 (enExample)
JP2017513836A5 (enExample)
JP2017537066A5 (enExample)
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
JP2016511753A5 (enExample)
JP2016539157A5 (enExample)
JP2015510916A5 (enExample)
JP2016027060A5 (enExample)
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
JP2015516419A5 (enExample)
RU2019110980A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
JP2013166781A5 (enExample)
CY1123346T1 (el) Παραγωγα 5-[2-(πυριδιν-2-υλαμινο)-1,3-θειαζολ-5-υλ]-2,3-διυδρο-1η-ισοϊνδολ-1-ονης και χρηση τους ως διπλοι αναστολεις της 3-κινασης φωσφατιδυλοϊνοσιτολης δελτα & γαμμα
JP2017505809A5 (enExample)
RU2015135824A (ru) Бициклические соединения пиримидона в качестве ингибиторов lp-pla2
WO2016057658A8 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
JP2016532632A5 (enExample)
RU2016112257A (ru) Композиция для лечения гипертензии и/или фиброза